Fogorvosi szemle, 2019 (112. évfolyam, 1-4. szám)

2019-12-01 / 4. szám

FOGORVOSI SZEMLE 112. évf. 4. sz. 2019.n 132 study. Epilepsia 2003; 44: 1103–1108. https://doi.org/10.1046/ j.1528-1157.2003.04003.x 31. KATO T, OKAHASHI N, KAWAI S, KATO T, INABA H, MORISAKI I, AMANO A: Impaired degradation of matrix collagen in human gingival fibro­blasts by the antiepileptic drug phenytoin. J Periodontol 2005; 76: 941–950. https://doi.org/10.1902/jop.2005.76.6.941 32. KEGLEVICH T, BENEDEK E, GERA I: A kalcium-csatorna-blokkoló szerek okozta ínyhyperplasia kezelésének klinikai tapasztalatai. FogorvSzle 1999; 92; 363–372. 33. kelekis-cHolakis a, WiltsHire Wa, birek c: Treatment and long­term follow-up of a patient with hereditary gingival fibromatosis: a case report. J Can Dent Assoc 2002; 68: 290–294. 34. KIMBALL OP: The treatment of epilepsy with sodium diphenyl hy­dantoinate. J Am Med Assoc 1939; 112: 1244–1245. https://doi .org/10.1001/jama.1939.02800130028009 35. KUO PJ, TU HP, CHIN YT, LU SH, CHIANF CY, CHEN RY, FU E: Cy­closporine-A inhibits MMP-2 and -9 activities in the presence of Porphyromonas gingivalis lipolysaccharide: an experiment in hu­man gingival fibroblast and U937 macrophage co-culture. J Peri ­odontal Res 2010; 47: 431–438. https://doi.org/10.1111/j.1600 -0765.2011.01450.x 36. kusztal m, raDWan-oczko m, kościelska-kasPrzak k, boratyńska m, Patrzałek D, klinger m: Possible association of CTLA-4 gene polymorphism with cyclosporine-induced gingival overgrowth in kidney transplant recipients. Transplant Proc 2007; 39: 2763– 2765. https://doi.org/10.1016/j.transproceed.2007.09.002 37. LEDERMAN D, LUMERMAN H, REUBEN S, FREADMAN PD: Gingival hy­perplasia associatec with nifedipin therapy. Oral Surg 1984; 54: 620–622. https://doi.org/10.1016/0030-4220(84)90283-4 38. MEIKLE MC, ATKINSON SJ, WARD RV, MURPHY G, REYNOLDS JJ: Gin­gival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: evidence that break­down is mediated by metalloproteinases. J Periodont Res 1989; 24: 207–213. https://doi.org/10.1111/j.1600-0765.1989.tb02007.x 39. moDéer t, brunius g, menDez c, Juntti-berggren l, berggren Po: Influence of phenytoin on cytoplasmic free Ca2+ level in human gingival fibroblasts. Scand J Dent Res 1991; 99: 310–315. https:// doi.org/10.1111/j.1600-0722.1991.tb01033.x 40. NARES S, NG MC, DILL RE, PARK B, CUTLET CW, IACOPINO AM: Cy­closporine A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva. J Periodontol 1996; 67: 271–278. https://doi.org/10.1902/jop.1996.67.3.271 41. NUKI I, COOPER SH: The role of inflammation in the pathogene­­sis of gingival enlargement during the administration of Dph in cats. J Periodont Res 1972; 7: 102–110. https://doi.org/10.1111/ j.1600-0765.1972.tb00635.x 42. ALMIÑana -Pastor PJ, buitrago-vera PJ, alPiste-illueca Fm: He­reditary gingival fibromatosis: Characteristics and treatment ap­proach J Clin Exp Dent 2017; 9: e599–602. doi: 10.4317/jced .53644 https://doi.org/10.4317/jced.53644 43. PERKS T1 [T1 VAGY TL?], POPAT H, CRONIN AJ, DURNING P, MAGGS R: The orthodontic and surgical management of Zimmerman-La­band syndrome. Orthodontics (Chic.) 2013; 14: e168–176. https:// doi.org/10.11607/ortho.897 44. POPPELL TD, KEELING SD, COLLINS JF, HASSELL TM: Effect of fo­lic acid on recurrence of phenytoin-induced gingival overgrowth following gingivectomy. J Clin Periodontol 1991; 18: 134–139. https://doi.org/10.1111/j.1600-051X.1991.tb01702.x 45. DHADSE PV, YELTIWAR RK, PANDILWAR PK, GOSAVI SR: Hereditary gingival fibromatosis. J Indian Soc Periodontol 2012; 16: 606– 609. https://doi.org/10.4103/0972-124X.106930 46. PRASAD VN, CHAWLA HS, GOYAL A, GAUBA K, SINGHI P: Incidence of phenytoin induced gingival overgrowth in epileptic children: a six month evaluation. J Indian Soc Pedod Prev Dent 2002; 20 (2): 73–80. 47. PRASAD VN, CHAWTA HS, GOYAL A, GAUBA K, SINGHI P: Folic acid and phenytoin induced gingival overgrowth – is there a preven­tive effect. J Indian Soc Pedod Prev Dent 2004; 22: 82–91. 48. ROSSMANN JA, INGLES E, BROWN RS: Multimodal treatment of drug­induced gingival hyperplasia in a kidney transplant patient. Com ­pendium 1994; 15: 1266, 68–76. 49. SALMAN BN, VALHABI S, MOVAGHAR, MAHJOUR F: Proliferative and inductive effects of Cyclosporine A on gingival fibroblast of child and adult. Dent Res J (Isfahan) 2013; 10: 52–58. doi: 10.4103/ 1735-3327.111777. 50. SEYMOUR RA, ELLIS JS, THOMASON JM: Risk factors for drug-in­duced gingival overgrowth. J Clin Periodontol 2000; 27: 217–223. https://doi.org/10.1034/j.1600-051x.2000.027004217.x 51. SEYMOUR RA, THOMASON JM, ELLIS JS: The pathogenesis of drug induced gingival overgrowth. J Clin Periodontol 1996; 23: 165– 175. https://doi.org/10.1111/j.1600-051X.1996.tb02072.x 52. SHI J1 [T1 VAGY TL?], LIN W, LI X, ZHANG F, HONG X: Heredi­tary gingival fibromatosis: a three-generation case and patho­genic mechanism research on progress of the disease. J Peri ­odontol 2011; 82: 1089–1095. https://doi.org/10.1902/jop.2010 .100599 53. SOGA Y, NISHIMURA F, OHTSUKA Y, ARAKI H, IWAMOTO Y, NARUISHI H, et al: CYP2C polymorphisms, phenytoin metabolism and gingi­val overgrowth in epileptic subjects. Life Sci 2004; 74: 827–834. https://doi.org/10.1016/j.lfs.2003.07.018 54. SUBRAMANI T, RATHNAVELU V, ALITHEEN NB: The possible potential therapeutic targets for drug induced gingival overgrowth. Media ­tors Inflamm 2013; 639468. https://doi.org/10.1155/2013/639468 55. SUKKAR TZ, THOMASON JM, CAWSTON TE, LAKEY R, JONES D, CATTER­ALL J, SEYMOUR RA: Gingival fibroblasts grown from cyclosporine­treated patients show a reduced production of matrix metallo­proteinase-1 (MMP-1) compared with normal gingival fibroblasts, and cyclosporin down-regulates the production of MMP-1 stimu­lated by pro-inflammatory cytokines. J Periodont Res 2007; 42: 580–588. https://doi.org/10.1111/j.1600-0765.2007.00986.x 56. THOMAS EA, PETROU S: Network-specific mechanisms may explain the paradoxical effects of carbamazepine and phenytoin. Epilep ­sia 2013; 54: 1195–1202. https://doi.org/10.1111/epi.12172 57. TIPTON DA, STRICKLIN GP, DABBOUS MK: Fibroblast heterogeneity in collagenolytic response to cyclosporine. J Cell Biochem 1991; 46: 152–165. https://doi.org/10.1002/jcb.240460209 58. TRACKMAN PC, KANTARCI A: Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med 2004; 15: 165–175. https://doi.org/10.1177/154411130401500305 59. TRIPATHI AK, UPADHAYA V, KUMAR V, SAIMBI CS: Hereditary gin­gival fibromatosis and its management: 2-year follow-up. Con ­temp Clin Dent 2014; 5: 569–571. https://doi.org/10.4103/0976 -237X.142835 60. VAHABI S, SALMAN BN, REZAZADEH F, NAMDARI M: Effects of cyclo­sporine and phenytoin on biomarker expressions in gingival fi­broblasts of children and adults: an in vitro study. J Basic Clin Physiol Pharmacol 2013; 25: 167–173. https://doi.org/10.1515/ jbcpp-2013-0003 61. ZHOU J, WINDSOR LJ: Heterogeneity in the collagen-degrading abil­ity of Porphyromonas gingivalis-stimulated human gingival fibro­blasts. J Periodontal Res 2007; 42: 77–84. https://doi.org/10.1111/ j.1600-0765.2006.00918.x

Next

/
  • Elrendezés
  • Igazítás
  • Forgatás
Oldalképek
Tartalom